Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-015620
Filing Date
2025-06-04
Accepted
2025-06-04 17:47:51
Documents
1
Period of Report
2025-06-02

Document Format Files

Seq Description Document Type Size
1 form4-06042025_090648.html 4  
1 form4-06042025_090648.xml 4 7532
  Complete submission text file 0001415889-25-015620.txt   9119
Mailing Address C/O HYPERION THERAPEUTICS, INC. 2000 SIERRA POINT PARKWAY, SUITE 400 BRISBANE CA 94005
Business Address
Holles Natalie C. (Reporting) CIK: 0001580111 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40431 | Film No.: 251024299

Mailing Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005 650 484-0899
Day One Biopharmaceuticals, Inc. (Issuer) CIK: 0001845337 (see all company filings)

EIN.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)